CDT Conduit Pharmaceuticals
- 0.102
- +0.002+1.50%
- 0.102
- +0.000+0.10%
Conduit Pharmaceuticals News
DEFA14A: Others
8-K: Current report
DEFA14A: Others
DEF 14A: Definitive information statements
S-3: Registration statement for specified transactions by certain issuers
PRE 14A: Preliminary proxy statements relating to merger or acquisition
8-K: Current report
S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
8-K: Current report
S-1: General form for registration of securities under the Securities Act of 1933
8-K: Current report
8-K: Current report
8-K: Current report
8-K/A: Current report (Amendment)
8-K: Current report
8-K: Current report
POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
8-K: Current report
Conduit Pharmaceuticals | NT 10-K: Others
Conduit Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Analysis
Price Target
No Data
No Data